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Gene delivery by negatively charged ternary
complexes of DNA, cationic liposomes and transferrin
or fusigenic peptides
˜
¨ ¨
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Potential problems with the use of viral vectors for gene
therapy necessitate the development of efficient nonviral
vectors. The association of transferrin, or the pH-sensitive
peptide GALA, with cationic liposomes composed of 1,2dioleoyl-3-(trimethylammonium) propane and its equimolar
mixture with dioleoylphosphatidylethanolamine, under conditions where the liposome/DNA complex is negatively
charged, drastically increased luciferase expression from
pCMVluc. The percentage of cells transfected, measured
by ␤-galactosidase expression, was also increased by
about 10-fold. The zeta potential of the ternary complexes
was lower than that of the liposome/DNA complexes.
Transfection activity of positively charged complexes was

also enhanced by association with transferrin, GALA or the
influenza hemagglutinin N terminal peptide HA-2, but to a
smaller extent compared with the negatively charged complexes. The enhancement of gene delivery by transferrin
or GALA was not affected significantly by the presence of
serum and did not cause significant cytotoxicity. Our
results indicate that negatively charged ternary complexes
of cationic liposomes, DNA and transferrin, or fusigenic
peptides, can facilitate efficient transfection of cultured
cells, and that they may alleviate the drawbacks of the use
of highly positively charged complexes for gene delivery
in vivo.
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Introduction
The feasibility of gene therapy for the treatment of genetic metabolic disorders, cancer and AIDS has been demonstrated in recent studies. Although various functional
reporter or therapeutic genes have been introduced into
cells in culture and the expression of these genes in various tissues has been shown in animal models,1–9 human
clinical trials have been disappointing, with only a few
individual cases of success.10–13 These results have
prompted calls for more basic research on vectors and
the cell biology of gene delivery.12 One of the major problems of gene therapy is the effective delivery of the therapeutic gene into target cells in vitro and in vivo. Although
viral vectors have certain advantages, including high levels of transfection, or efficient and stable integration of
foreign DNA into a wide range of host genomes, they
suffer from several problems. These include immunogenicity, toxicity, difficulty of large-scale production, size
limit of the exogenous DNA, random integration into the
host genome in the case of retroviruses, and the risks of
inducing tumorigenic mutations and generating active
viral particles through recombination.14,15 These limitations of viral vectors have prompted investigators to try
to improve methods of nonviral gene delivery.6
¨ ¨
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Cationic liposomes, have been used extensively for in
vitro and in vivo gene delivery, and constitute a viable
alternative to viral gene delivery vehicles.14,16,17 Using
this delivery system, relatively stable expression has been
achieved in a number of tissues.18–23 Although liposomal
vectors have several advantages, including lack of
immunogenicity, safety, ability to package large DNA
molecules and ease of preparation,14,15,17 they have a limited efficiency of delivery and gene expression, toxicity
at higher concentrations, potentially adverse interactions
with biological milieux rich in negatively charged macromolecules, and inability to reach tissues beyond the vasculature unless directly injected into the tissue.15,24–27
Genes delivered in vivo via cationic liposomes are
expressed primarily in cells of the vascular compartment,20,21 although transgene expression has also been
noted in deep tissues.20,22 Cationic liposome–DNA complexes (‘lipoplexes’28) may be coated with serum proteins
such as lipoproteins and albumin, or bind nonspecifically
to cells such as erythrocytes, lymphocytes and endothelial cells, as well as to extracellular matrix proteins.
This may limit the ability of the complexes to reach target
tissues and cells.14,16,24
Cationic liposome–DNA complexes with a net positive
charge bind electrostatically to the negatively charged
cell surface. We investigated whether cationic liposome–
DNA complexes with a net negative or neutral charge
could be utilized for gene delivery by facilitating the
binding of the complexes to cell membrane receptors and
their subsequent internalization in endosomes. We
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employed transferrin to target liposome–DNA complexes
to cell surface transferrin receptors and examined the
transfection activity and efficiency of these ternary complexes at different lipid/DNA (+/−) charge ratios. Our
results indicate that net negatively charged ternary complexes of transferrin/cationic liposomes/DNA can be
more effective in mediating gene delivery than positively
charged complexes.
The mechanisms by which cationic liposomes deliver
DNA into cells are not well understood and are being
investigated. One proposed mechanism is that the complex is first endocytosed and then destabilizes the endosomal membrane, thereby microinjecting the DNA into
the cytoplasm.25,29–32 Fusion peptides of certain viral
envelope proteins are known to mediate membrane
fusion at the mildly acidic pH achieved in endosomes.
We investigated the effect on transfection of two different
synthetic fusigenic peptides, ‘GALA’33,34 and the influenza virus hemagglutinin HA2 N-terminal peptide,35
associated with the cationic lipid/DNA complexes. Our
rationale was that these peptides would facilitate the
destabilization of the endosome membrane36,37 thereby
mediating the release of DNA into the cytoplasm. We
have found that GALA can enhance the transfection
activity of lipoplexes even under conditions where the
ternary complex is net negatively charged. Some of our
results have been presented previously in preliminary
form.38,39

Results
Enhancement of transfection of HeLa cells by a
targeting ligand
The limited efficiency of transfection mediated by nonviral vectors, especially when compared with that by
viral vectors, is one of the main restrictions to the more
frequent use of these systems in gene therapy. In an
attempt to overcome this limitation, several authors have
used targeting ligands to enhance the binding and internalization of nonviral vectors.40–42 Another limitation to
the use of cationic liposomes is their interaction with
negatively charged macromolecules present in serum or
the extracellular matrix. We examined whether complexes of cationic liposomes and DNA that have a net
negative charge could mediate transfection in the presence of targeting ligands. For this purpose we prepared
liposomes containing either DOTAP:DOPE or pure
DOTAP complexed with transferrin and DNA at different cationic lipid/DNA charge ratios.
Figure 1 shows the levels of transfection of HeLa cells
obtained with different lipid/DNA (+/−) charge ratios in
the presence or absence of transferrin. The presence of
transferrin enhanced transfection for all the lipid/DNA
charge ratios tested. However, it is of interest to observe
that this enhancement is particularly pronounced for the
negatively charged complexes. For example, for the 1/2
lipid/DNA charge ratio the enhancement of transfection
activity was more than 750-fold. It is also interesting to
note that in the presence of transferrin the highest levels
of transfection were obtained for the 1/1 (theoretically
neutral) lipid/DNA charge ratio. This observation suggests that a net positively charged lipid/DNA complex
is not required to obtain relatively high levels of transfection. In fact, when complexes with 2/1 and 4/1

Figure 1 The effect of transferrin complexation with DOTAP:DOPE liposomes on luciferase gene expression in HeLa cells. Cells were rinsed twice
with serum-free medium and then covered with 0.3 ml of DME-HG before
lipid/DNA complexes were added. The liposomes were complexed, in the
presence or absence of 32 g of transferrin, with 1 g of pCMVluc at
the indicated theoretical lipid/DNA charge ratios. After an incubation for
4 h, the medium was replaced with DME-HG containing 10% FBS and
the cells were further incubated for 48 h. The level of gene expression was
evaluated as described in Materials and methods. The data are expressed
as ng of luciferase per mg of total cell protein (mean ± standard deviation
obtained from triplicate wells) and are representative of two independent experiments.

lipid/DNA (+/−) charge ratios were tested, luciferase
expression decreased compared with that of the 1/1 complex. These results also indicate that higher positive to
negative charge ratios do not enhance gene transfer or
expression mediated by transferrin. A similar tendency
was also observed for the plain lipid/DNA complexes.
Highly positively charged complexes have been proposed to be more stable in the biological milieu, since an
excess of positive charge may result in a more compact
or condensed complex, enabling better protection of the
DNA molecule against nucleases.43 However, for the
same reasons (ie more stable or compact DNA) a decrease
of transfection may also occur (as obtained with the 2/1
and 4/1 lipid/DNA complexes) due to the difficulty of
dissociation of DNA from the complex and its subsequent release into the cytoplasm. In this respect, Zabner
et al25 have found that the transcription of positively
charged lipid/DNA complexes microinjected into oocyte
nuclei is much lower than that of negatively charged
complexes.
Similar results were obtained when pure DOTAP liposomes were complexed with pCMVluc in the presence
or absence of transferrin (Figure 2). The enhancement of
transfection when the DOTAP complexes were associated
with transferrin was even more pronounced than that
observed with DOTAP:DOPE liposomes, particularly
since gene expression with the DOTAP complexes without transferrin was lower than that obtained with
DOTAP:DOPE. We should note that the results in Figures
1 and 2 may be directly compared since they were
obtained with the same batch of cells. Several studies
have found that DOPE is the most efficient helper lipid
for in vitro gene transfection,31,44,45 most likely because of
its tendency to form nonbilayer phases and to facilitate
membrane fusion.46,47 Our results with the control liposomes, ie in the absence of transferrin (Figures 1 and 2),
also indicate that DOTAP:DOPE liposomes mediated
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Figure 2 The effect of transferrin complexation with DOTAP liposomes
on luciferase gene expression in HeLa cells. Experiments were performed
as described in the legend to Figure 1. The data, expressed as ng of luciferase per mg of total cell protein, indicate the mean ± standard deviation
obtained from triplicate wells and are representative of two independent
experiments.

higher transfection activity than pure DOTAP liposomes.
Nevertheless, in the presence of transferrin, this difference was not particularly apparent.
To evaluate the specificity of transferrin in enhancing
gene delivery, anionized human serum albumin was
complexed with DOTAP/DOPE liposomes and DNA at
1/1 and 2/1 lipid/DNA (+/−) charge ratios, in the same
manner as transferrin. No enhancement of transfection
was observed in HeLa cells above that obtained with the
plain lipoplexes (data not shown). Furthermore, the
copolymer VM-Acp, which was also net negatively
charged, did not enhance transfection when complexed
with lipoplexes (data not shown).

Enhancement of transfection by pH-sensitive synthetic
peptides
Recent studies on the mechanism by which cationic liposomes deliver DNA into cells have pointed out endocytosis as the main process of internalization for the
lipid/DNA complexes.25,29–31 Therefore, destabilization of
the endosomal membrane and consequent release of the
complexes or free DNA into the cytoplasm before lysosomal degradation can occur, appear to be crucial steps for
efficient gene delivery. In an attempt to surpass this limiting step, Wagner and collaborators35 have utilized, in
conjunction with transferrin-polylysine–DNA complexes,
fusigenic peptides that destabilize liposomes, erythrocytes and endosomes in a low pH-dependent manner.
The association of HA-2-derived peptides or the pHsensitive 30-amino acid peptide, ‘GALA’, with DNA–
transferrin-polylysine complexes resulted in a significant
enhancement of the expression of luciferase in cells transfected with these complexes.35,37 We tested the effect of
some of these synthetic peptides on the transfection of
HeLa cells with the pCMVLuc plasmid mediated by
DOTAP:DOPE liposomes at different lipid/DNA charge
ratios. The association of the GALA peptide with the
complexes resulted in an enhancement of transfection of
HeLa cells (Figure 3). The association of 0.6 g of GALA
with complexes of 2/1 (+/−) charge ratio resulted in a
four-fold increase in the level of luciferase expression
compared with controls. For the 1/1 and 4/1 charge
ratios only a slight increase was observed. The use of a
higher GALA concentration (1.2 g per well) also
resulted in larger transfection activities in the case of 2/1
and 4/1 ratios compared with those for controls. Nevertheless, doubling the peptide concentration did not result
in any significant increase in the levels of luciferase
expression. No effect was observed when a lower peptide
concentration (0.3 g per well) was used (data not
shown).

Figure 3 The effect of association of fusigenic peptides to DOTAP:DOPE liposomes on luciferase gene expression in HeLa cells. The liposomes were
complexed with 0.6 or 1.2 g of GALA or HA-2-derived peptides and with 1 g of pCMVluc at the indicated theoretical lipid/DNA charge ratios as
described in detail in Materials and methods. The data (expressed as ng of luciferase per mg of total cell protein) are the mean ± standard deviation
obtained from triplicate wells, and are representative of two independent experiments.
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To examine whether the acidification of endosomes is
involved in the enhancement of transfection by GALA,
we pretreated cells with bafilomycin A1, which is a specific inhibitor of the endosomal proton-ATPase48–50 under
conditions where no cytotoxicity was observed. This
treatment resulted in the reduction of transfection for
both the 1/1 and the 2/1 complexes to about 50% of
untreated controls (data not shown). This observation
indicates that at least part of the enhancing activity of
GALA is due to the acidic environment in endosomes.
A similar tendency was observed for the HA-2-derived
peptide. The association of 0.6 g peptide (per well) with
complexes of 2/1 charge ratio resulted in an enhancement of transfection over controls. An increase in the
amount of peptide added did not result in a proportional
enhancement of transfection, even though the levels achieved with 1.2 g peptide were higher than controls.

Effect of transferrin and GALA on transfection of COS-7
cells
Different cell lines exhibit largely varying levels of transfection activity with the same gene vector.44,51,52 To test
whether DOTAP:DOPE/DNA complexes associated with
transferrin or GALA were also effective in other cell lines
we performed experiments with COS-7 cells which have
been used in previous transfection studies (Figure 4).51
As observed for HeLa cells, the association of transferrin
or the GALA peptide with the lipid/DNA complexes
resulted in a significant enhancement of the levels of
luciferase expression in COS-7 cells. It should be noted,
however, that the levels of transfection for COS-7 cells
were in general much higher than those obtained with
HeLa cells, and that the dependence of transfection on
the charge ratio was different when GALA was associated with the complexes. In fact, with COS-7 cells transfection in the presence of 0.6 g peptide per well was optimal with the 1/1 lipid/DNA charge ratio, while with
HeLa cells, the optimal ratio was 2/1. It is also of interest

that a dramatic enhancement of luciferase expression was
observed in the presence of transferrin at the 1/2 charge
ratio (Figure 4).

Evaluation of transfection efficiency
To investigate whether the enhancement of transfection
mediated by the association of transferrin or the fusigenic
peptides was due to an increase in the number of cells
transfected or only due to an enhancement of gene
expression, we evaluated the transfection efficiency,
defined as the percentage of treated cells that express the
transgene. For this purpose the plasmid pCMV.SPORT
encoding ␤-galactosidase was associated with the complexes and cells transfected as described in Materials and
methods. The results, presented as the percentage of cells
scored for the expression of ␤-galactosidase (blue cells)
are shown in Table 1. The association of transferrin or
fusigenic peptides with the lipid/DNA complexes
resulted in an increase of the number of cells that were

Table 1 Expression of ␤-gal in HeLa cells (% of blue cells).
Effect of the association of transferrin or fusigenic peptides with
DOTAP:DOPE/DNA complexes of different charge ratios
Charge ratio
(lipid/DNA)

1/2

1/1

2/1

Control
+ Transferrin
+ GALA peptide

0
5–10

1–2
20–25
5

1
5
5–7

The liposomes were complexed, in the presence or absence of
32 g of transferrin or 0.6 g of the GALA peptide, with 1 g
of pCMV.SPORT-␤-gal at the indicated theoretical lipid/DNA
charge ratios. ␤-Gal expression was observed as described in
Materials and methods. The percentage of cells exhibiting ␤-gal
activity was evaluated by counting 1000 cells in duplicate wells.

Figure 4 Evaluation of the transfection activity in COS-7 cells mediated by DOTAP:DOPE liposomes with or without transferrin or the GALA peptide.
Cells were rinsed twice with serum-free medium and then covered with 0.3 ml of DME-HG before lipid/DNA complexes were added. The preparation
of the complexes and the transfection procedure were performed as described in Materials and methods. The data are expressed as ng of luciferase per
mg of total cell protein (mean ± standard deviation obtained from triplicate wells) and are representative of two independent experiments.
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detectably transfected. In the case of the 1/1 charge ratio
complexes, the percentage of cells scored as expressing
␤-galactosidase increased from 2 for controls to 25% with
transferrin, and from 1 to 5%, respectively, with the
GALA peptide. These results suggest that a correlation
between transfection activity (level of luciferase
expression) and transfection efficiency (the percentage of
cells transfected) can be established in this system. It
should be noted that our experiments were not designed
to maximize the efficiency of transfection, but to explore
the roles of transferrin, fusigenic peptides and the +/−
charge ratio in transfection activity and efficiency. For
example, it may be possible to enhance transfection
activity and efficiency by using higher amounts of DNA.
This, however, may result in cytotoxicity26 because of the
necessity to use higher quantities of cationic liposomes
to obtain the same charge ratios as those used in the
present study.

Effect of serum on transfection
Transfection of certain cell types by some cationic liposome compositions is sensitive to the presence of
serum.51,53,54 The inhibition of gene delivery by serum is
considered to be one of the limitations to their application
in vivo.54 Therefore, the effect of serum on the levels of
transfection mediated by the above described complexes
was also examined. For this purpose, complexes were
added to cells in the presence of cell culture medium containing 10% FBS and incubated for 4 h at 37°C, as
described in Materials and methods. Figure 5 illustrates
the level of transfection observed when control complexes, or transferrin- or GALA peptide-associated complexes at different lipid/DNA charge ratios were used
under these conditions. The presence of serum did not
appreciably change the levels of transfection for the different complexes tested (compare with Figures 1 and 3).
These data suggest that the complexes (either net negatively or positively charged, or neutral) remain effective

despite any possible interaction with serum components.
The fact that transfection mediated by the DOTAP:DOPE
liposomes, with or without transferrin or fusigenic peptides, is not affected by the presence of serum not only
results in a simplification of the transfection procedure,
since the washing steps can be eliminated, but also
increases the likelihood that these complexes can be utilized for gene delivery in vivo.

Zeta potential measurements
In an attempt to gain some insights into the mechanisms
by which the cationic liposome–DNA complexes at different (+/−) charge ratios interact with the cells we examined the overall charge of the complexes by zeta potential
measurements, using a Coulter DELSA 440 instrument
(Coulter Electronics, Hialeah, FL, USA). The effect on the
zeta potential of the presence of transferrin or fusigenic
peptides in the complex was also determined (Table 2).
The values of the zeta potential of DOTAP:DOPE–DNA
complexes for the different (+/−) charge ratios were in
agreement with what was expected from the theoretical
calculations based on their charge. Complexes containing
an excess of DNA to lipid (1/2, +/− charge ratio) exhibited an overall net negative charge. Moreover, 1/1 complexes were in fact neutral, and 2/1 and 4/1 complexes
were net positively charged.
The association of transferrin with the complexes
resulted in a decrease of the zeta potential for all the
charge ratios tested. This effect is most likely due to the
negatively charged amino acids of the protein interacting
with the cationic liposomes. The zeta potential of the
lipid/DNA complex at a 1/1 (+/−) charge ratio decreased
from 2 mV to −39 mV in the presence of transferrin. The
zeta potential also decreased upon addition of 0.6 g of
GALA or HA-2-derived peptide to the 2/1 or 4/1 complexes. It should be noted that complexes presenting a
net negative charge are those that exhibit higher transfection activity (Table 2, Figure 3).

Figure 5 The effect of the presence of serum on luciferase gene expression in HeLa cells. Cells were covered with 0.3 ml of DME-HG enriched with
10% FBS before lipid/DNA complexes were added. The liposomes were complexed, in the presence or absence of 32 g of transferrin or 0.6 of the GALA
peptide, with 1 g of pCMVluc at the indicated theoretical lipid/DNA charge ratios. After an incubation of 4 h, the medium was replaced with 1 ml
of medium containing 10% FBS and the cells were further incubated for 48 h. The level of gene expression was evaluated as described in Materials
and methods. The data are expressed as ng of luciferase per mg of total cell protein. Data represent the mean ± standard deviation obtained from triplicate
wells. Note that in this experiment the 4/1 lipid/DNA charge ratio was not tested for the plain lipoplexes and the complexes with transferrin, and the
1/2 charge ratio was not tested in the case of complexes containing GALA.
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Table 2 The zeta potential (mV) of liposome–DNA complexes at various charge ratios (+/−) and the effect of transferrin and fusigenic peptides
Charge ratio (+/−)
(lipid/DNA)

Zeta potential (mV)
1/2

DOTAP:DOPE/DNA
DOTAP:DOPE/DNA + Transferrin
DOTAP:DOPE/DNA + GALA 0.6 g
DOTAP:DOPE/DNA + Influenza 0.6 g

−32.75 ± 4.8
−47.8 ± 4.7

1/1
2.44 ± 5.1
−38.6 ± 5.2

2/1
42.75 ± 0.5
25 ± 2.16
−35.25 ± 3.6
−11 ± 3.5

4/1
48.6 ± 1.9
44 ± 4.3
32 ± 3.55
8 ± 2.9

Zeta potential measurements of the different DOTAP:DOPE/DNA complexes were performed using a Coulter DELSA 440 instrument.
Data represent the mean ± standard deviation obtained for the different angles in two measurements.

The effect of the different complexes on cell viability
Cationic liposomes can be toxic to cells, depending on
the lipid concentration, duration of treatment, the cell
type and the confluency of the culture.26,51 To evaluate
whether DOTAP:DOPE/DNA complexes were toxic to
cells, cell viability was assessed following transfection.
The colorimetric Alamar Blue assay measures the redox
capacity of cells due to the production of metabolites, as a
result of cell growth and allows determination of viability
over the culture period without the detachment of adherent cells. Cell viability was not affected significantly
when DOTAP:DOPE/DNA complexes were incubated
for 4 h at 37°C with HeLa cells, followed by a 48-h incubation (Figure 6). Cell metabolic activity was unaltered
even for the highest lipid/DNA charge ratio tested (2/1),
where about 8 g of total lipid were used. The addition
of transferrin or the fusigenic peptides also did not result
in any toxicity to the cells. These results were confirmed
by both total cell protein quantification and morphological observations for treated and untreated cells (data
not shown).

Discussion
Nonviral gene delivery systems appear to be very promising systems for gene therapy since they obviate some
of the safety limitations associated with viral vectors. As
an example of such systems, cationic liposomes, first proposed by Felgner et al,51 have been used extensively in
vitro and in vivo. Although a large amount of effort has
been made for the development of these vectors, namely
through the synthesis and evaluation of different lipid
compositions, as well as of new plasmids with more
efficient promoters, the results are still unsatisfactory.
The heterogeneity of the complexes formed with the plasmid DNA, the lack of knowledge of the mechanisms by
which these systems mediate gene delivery, toxicity
under certain conditions, sensitivity to the presence of
serum and especially the low levels of gene expression
in vitro and in vivo (compared with viral vectors) raise
doubts regarding their potential as gene delivery systems
in clinical studies.
We explored two different approaches of enhancing

Figure 6 Effect of DOTAP:DOPE/DNA complexes, with or without transferrin or fusigenic peptides, on the viability of HeLa cells. Cells in 48-well
plates were exposed to lipid/DNA complexes at different charge ratios for 4 h at 37°C as described in Materials and methods. Cell viability was measured
by the Alamar Blue assay following 48 h of incubation and was expressed as the percentage of the untreated control cells. Data represent the mean ±
standard deviation obtained from duplicate wells.
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the transfection mediated by DOTAP:DOPE liposomes:
(1) to promote cellular internalization of the cationic liposome–DNA complexes through receptor-mediated endocytosis; and (2) to improve the cytoplasmic release of
DNA from endosomes, preventing their lysosomal degradation.
Targeting to cellular transferrin receptors had been
tried successfully before by linking the ligand to polycation conjugates40,55 or by associating the protein with
cationic liposomes.42 The latter study reported the use of
iron-saturated human transferrin associated to Lipofectin
reagent, composed of the cationic lipid N-[2,3(dioleoyloxy)propyl]-N,N,N-trimethylammonium (DOTMA) and the zwitterionic lipid DOPE,51 and showed significant differences in the levels of ␤-galactosidase
expression depending on the amount of transferrin
added to the complexes, time of transfection and methodology of preparation of the complexes. The study showed
that the transerrin complexes delivered a two-fold higher
amount of DNA to the cells compared with plain lipoplexes at early time-points and that the amount of DNA
associated with the cells decreased after a 5-h incubation
with the cells. Cheng42 postulated a model for the formation of an efficient gene transfer vector composed of
transferrin and Lipofectin. Complexation of LipofectAMINE with transferrin did not result in enhanced gene
expression, while LipofectACE–transferrin complexes
significantly increased transfection efficiency and
activity.
Using liposomes composed of pure DOTAP or
DOTAP:DOPE (1:1, weight ratio) we added iron-saturated human transferrin to the liposomes before the
addition of the reporter plasmids. Our study is the first
to establish the role of the +/− charge ratio in the
enhancement of transfection by transferrin (Figures 1 and
2). The similarity between the structures of DOTMA and
DOTAP may explain why transferrin was able to enhance
gene delivery by DOTAP:DOPE liposomes as well as
by Lipofectin.
The use of transferrin with the rationale to target the
cationic liposome–DNA complexes to cell surface receptors and to enhance receptor-mediated uptake, drastically
increases the transfection activity and efficiency of the
transferrin/cationic liposome/DNA ternary complexes.
Despite the highest levels of luciferase expression achieved with complexes of 1/1 (+/−) charge ratio, the most
dramatic effect of transferrin is illustrated by the results
obtained with the negatively charged complexes (1/2).
Although, these conditions were suboptimal for condensing and complexing DNA, it was possible, by adding
transferrin, to increase transfection from essentially null
to relatively high values of gene expression. The effect of
transferrin was not so evident for the positively charged
complexes. It seems that an excess of positive charge
masks the presence of the ligand, thus decreasing the
efficiency of the receptor-mediated endocytotic process.
Indeed, from the combination of the transfection results
for both cell lines and the zeta potential values, it is clear
that there is an ideal range of charge ratios where transfection is more efficient. Surprisingly, complexes that
bear a net negative charge in the presence of transferrin
(or the peptides) are those leading to the highest levels
of gene expression. With this system, high levels of transfection could be achieved with relatively low DNA and

liposome concentrations, which also resulted in lack of
any significant cytotoxicity.
On the other hand, the use of low pH-activated membrane-active peptides, with the rationale to induce the
destabilization of endosomes, also results in an enhancement of transfection. The lower levels of transfection
activity obtained with GALA compared with those for
transferrin suggest that internalization of the complexes
represents the major barrier to be surpassed in order to
enhance gene transfer. In our studies the synthetic GALA
peptide was more effective than the influenza HA-2 peptide. Two previous studies have shown the enhancement
of cationic liposome-mediated transfection by synthetic
peptides derived from influenza hemagglutinin
sequences.50,56 Kamata et al56 used anionic or cationic
derivatives of the N-terminal peptide of the HA2 subunit
of hemagglutinin and obtained between two- and sevenfold enhancement of transfection activity over that of
Lipofectin alone. Kichler et al50 were able to increase the
levels of Transfectam (lipopolyamine)-mediated transfection by three- to 30-fold by employing various influenzaderived peptides. It has been shown that GALA (a 30amino acid, pH-sensitive, ␣-helical amphipathic peptide)
undergoes a transition from a random coil at pH 7.5 to an
amphipathic ␣-helix at pH 5.0, under which conditions it
strongly interacts with phospholipid membranes to
induce fusion, contents leakage, and phospholipid flipflop.33,34,57,58 It is interesting to note that the association
of GALA with the lipid/DNA complexes led to a higher
enhancement of luciferase expression in COS-7 cells than
in HeLa cells, the levels being similar to those observed
with transferrin. Thus, in COS-7 cells internalization of
the ternary complexes does not appear to be a rate-limiting step. These observations raise the possibility that the
use of the GALA peptide may be an even more effective
strategy to enhance gene transfer mediated by cationic
liposomes in other types of cells. We have recently
reported that the combined use of GALA and transferrin
with lipoplexes results in successful transfection of
human monocyte-derived macrophages.59 Thus, both
internalization and endosome disruption appear to be
important barriers to be overcome in gene delivery to
macrophages.
Synthetic peptides containing 16 to 20 amino acids of
the influenza HA-2 amino terminus induce liposome
fusion and cause leakage of aqueous liposomal contents
at acidic pH.35 Our use of a similar synthetic peptide (20
amino acids) as a strategy to improve the cytoplasmic
delivery of DNA is based on the expectation that this
peptide will adopt an ␣-helical conformation in the endosome, upon protonation of carboxyl groups, leading to
the destabilization of the endosomal membrane.
Although this peptide promoted transfection as compared with controls, the observed enhancement was not
as significant as in the case of the GALA peptide or transferrin. In gene transfer experiments utilizing polylysine–
transferrin complexes and BNL CL.2 hepatocytes, monomeric influenza peptides, including INF2 with an identical sequence to our HA-2 peptide, did not significantly
enhance gene transfer.37 HA-2 peptide derivatives
obtained either by elongation or dimerization were
shown to be more effective than the peptides themselves
in gene delivery; these peptides also displayed endosome
disruption activity.37 The association of such modified
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peptides with lipoplexes may be an effective method to
enhance transfection.
Although the use of a targeting ligand and fusigenic
peptides for enhancing gene delivery is based on a
rational strategy, the actual mechanisms by which these
agents enhance transfection are not known and are under
investigation. The gene targeting specificity of transferrin
covalently coupled to polyethylenimine has been demonstrated recently.60 Our experiments with a negatively
charged albumin used as a control nonspecific protein
indicated no enhancement of gene delivery over that
obtained with plain lipoplexes. In the case of influenzaderived peptides, Kichler et al50 have shown that the
enhancement of lipopolyamine-mediated transfection is
independent of the pH sensitivity of the peptides. For
example, the peptide INF6 induces the leakage of liposome contents both at acidic and neutral pH, and
enhances relative light units of luciferase by more than
an order of magnitude, while INF10 induces leakage in
a pH-dependent manner and enhances transfection to a
slightly lower extent than INF6. As would be expected
from the relative pH sensitivities of the two peptides,
INF10 is more sensitive to the inhibitory action of bafilomycin A1 than INF6.50 It should be noted that Kichler
et al50 added the peptides to preformed lipoplexes,
whereas in our study the peptides and cationic liposomes
were complexed before the addition of DNA. Gene delivery and expression mediated by the GALA lipoplexes
used in our study were also inhibited by bafilomycin A1,
although to a lower extent than that observed for INF10
in the study by Kichler et al.50 The latter authors found
that a pH-sensitive GALA analogue, EGLA-I, also
enhanced transfection. When complexed to transferrin–
polylysine conjugates, influenza-derived peptides with
the highest pH specificity (INF4D1, INF5 and INF7) with
respect to mediating erythrocyte lysis appear to be at
least an order of magnitude more active in gene delivery
than peptides without the pH specificity (INF6, INF-A).61
A correlation between the enhancement of transfection
activity (evaluated by the level of luciferase expression)
and the increase in the number of cells successfully transfected (cells scored as expressing ␤-galactosidase) was
observed. However, the enhancement of the number of
cells transfected due to the presence of transferrin or the
fusigenic peptides was lower than expected, especially in
comparison with Cheng’s results,42 where almost 100%
of HeLa cells were transfected. Even considering the subjectivity involved in scoring the assay, our results, using
the same cell line, are far from these ideal values. Nevertheless, it should be pointed out that a different plasmid
for ␤-galactosidase was used by Cheng,42 thus making
a direct comparison difficult. Evaluation of transfection
efficiency by scoring cells expressing human green fluorescent protein (hGFP) also indicated that only a relatively low percentage of cells were transfected successfully (unpublished data).
The association of transferrin and fusigenic peptides to
lipid/DNA complexes as an attempt to enhance transfection may overcome some of the limitations associated
with the use of cationic liposomes in gene therapy.
Indeed, the ternary complexes of cationic liposomes,
DNA and protein or peptide, not only lead to high levels
of transfection, but also have the advantage of being
active in the presence of serum and being nontoxic. Moreover, such negatively charged ternary complexes are

likely to alleviate the problems associated with the use
of highly positively charged complexes in vivo, such as
avid complexation with serum proteins. These complexes, and their future derivatives, may thus be potential
alternatives to viral vectors for gene delivery in vivo.

Materials and methods
Materials
The cationic lipid 1,2-dioleoyl-3-(trimethylammonium)
propane (DOTAP), and dioleoylphosphatidylethanolamine (DOPE), were purchased from Avanti Polar Lipids
(Alabaster, AL, USA). Iron-saturated, heat-inactivated
human transferrin was obtained from Collaborative
Biomedical Products (via Becton Dickinson, Bedford,
MA, USA). The GALA peptide33,34 and the peptide
named HA-2, derived from the N-terminal sequence of
the influenza virus hemagglutinin subunit HA235 were
synthesized and purified by the UCSF Biomolecular
Resource Center. Succinylated human serum albumin,
and a copolymer of vinylpyrrolidone and maleic anhydride modified with epsilon-aminocaproic acid (VMAcp) were kindly provided by Dr Sergei Andreev, Institute of Immunology, Moscow. The pCMVluc plasmid
(VR-1216) was a generous gift of Dr P Felgner (Vical, San
Diego, CA, USA). The plasmid pCMV.SPORT-␤-gal and
the ␤-gal staining kit were obtained from Gibco BRL Life
Technologies (Gaithersburg, MD, USA) and Invitrogen
(San Diego, CA, USA), respectively. Alamar Blue dye was
purchased from Alamar Biosciences (Sacramento, CA,
USA). NaCl, 2-[N-morpholino]ethanesulfonic acid (MES),
N-[2-hydroxyethyl] piperazine-N⬘-[2-ethanesulfonic acid]
(HEPES) were obtained from Sigma (St Louis, MO, USA).
Liposome preparation
Cationic liposomes composed of DOTAP or DOTAP:
DOPE (1:1 weight ratio) were prepared by first drying a
film of lipid under argon and then in a vacuum oven at
room temperature, and hydrating the lipid film with
1 ml deionized water at a final concentration of 5 mg/ml.
The multilamellar vesicles obtained were then sonicated
briefly under argon, extruded 21 times through polycarbonate filters of 50 nm pore diameter using a Liposofast
device (Avestin, Toronto, Canada), diluted five times
with deionized water and filter-sterilized utilizing Millex
(Keene, NH, USA) 0.22 m pore-diameter filters.
Cells
HeLa cells (American Type Culture Collection, MD,
USA) were maintained at 37°C, under 5% CO2, in Dulbecco’s modified Eagles’s medium-high glucose (DME-HG)
(Irvine Scientific, Santa Ana, CA, USA) supplemented
with 10% (v/v) heat-inactivated fetal bovine serum (FBS;
Sigma), penicillin (100 units/ml), streptomycin (100
g/ml) and l-glutamine (4 mm). For transfection,
0.2 × 106 HeLa cells were seeded in 1 ml of medium in 48well culture plates and used at 80–90% confluence. COS-7
cells (UCSF Cell Culture Facility, San Francisco, CA,
USA) were maintained under the same conditions
described for HeLa cells. For transfection, cells were
seeded in 1 ml of medium in 48-well culture plates and
used at 40–60% confluence.
Preparation of the ternary complexes
Complexes were prepared by sequentially mixing 100 l
of a solution of 100 mm NaCl, 20 mm Hepes, pH 7.4, with
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or without 32 g iron-saturated human transferrin42 with
2.5, 5, 10 or 20 l liposomes and incubated at room temperature for 15 min. One hundred microliters of buffer
containing 1 g of pCMVluc or 1 g pCMV.SPORT ␤gal plasmid was then added and gently mixed, and the
mixture was further incubated for 15 min at room temperature. Peptide complexes were prepared in a similar
manner, with varying amounts of peptide, as indicated
in the Figures.

placed in the measuring cell, whose position was
adjusted to cover a previously determined stationary
layer, and an electric current of 3.0 mA was applied.
Measurements were recorded and the zeta potential ()
was calculated for each scattering angle (8.6°, 17.1°, 25.6°
and 34.2°). Data represent the mean ± standard deviation
obtained for the different angles of two measurements.

Transfection activity
Cells were rinsed twice with serum-free medium and
then covered with 0.3 ml of DME-HG before lipid/DNA
complexes were added. Lipid/DNA complexes were
added gently to cells in a volume of 0.2 ml per well. After
an incubation for 4 h (in 5% CO2 at 37°C) the medium
was replaced with DME-HG containing 10% FBS, and the
cells were further incubated for 48 h. The cells were then
washed twice with phosphate-buffered saline (PBS) and
100 l of lysis buffer (Promega, Madison, WI, USA) were
added to each well. The level of gene expression in the
lysates was evaluated by measuring light production by
luciferase using a scintillation counter protocol
(Promega). The protein content of the lysates was measured by the Dc Protein Assay reagent (Bio-Rad, Hercules,
CA, USA) using bovine serum albumin as the standard.
The data were expressed as ng of luciferase (based on
a standard curve for luciferase activity), per mg of total
cell protein.

This work was supported by JNICT, PRAXIS XXI (BD
4056/94) and in part by the National Institutes of Health
(AI-35231) and funds from the University of the Pacific
School of Dentistry. We thank Dr Shlomo Nir (Hebrew
University of Jerusalem) and Dr Krystyna Konopka
(University of the Pacific) for helpful discussions.

Transfection efficiency
Transfection efficiency was evaluated by scoring the percentage of cells expressing ␤-galactosidase. Briefly, cells
transfected with 1 g of pCMV.SPORT-␤-gal were
washed with PBS, fixed in a solution of 2% formaldehyde
and 0.2% glutaraldehyde, and stained with an X-gal containing solution. The cells were incubated at 37°C for 24
h and then examined under a phase contrast microscope
for the development of blue color. The percentage of cells
exhibiting ␤-gal activity was evaluated by counting 1000
cells in duplicate wells.
Cell viability assay
Cell viability following transfection under the different
experimental conditions was quantified by a modified
Alamar Blue Assay.62 Briefly, 1 ml of 10% (v/v) Alamar
Blue dye in complete DME medium was added to each
well 45 h after transfection. After 2.5–4 h of incubation
at 37°C, 200 l of the supernatant were collected from
each well and transferred to 96-well plates. The
absorbance at 570 nm and 600 nm was measured with a
microplate reader (Molecular Devices, Menlo Park, CA,
USA). Cell viability (as a percentage of control cells) was
calculated according to the formula (A570–A600) of treated
cells × 100/(A570–A600) of control cells.
Zeta potential measurements
Zeta potential measurements of the different lipid/DNA
complexes, and ternary complexes with transferrin or
peptides, were performed using a Coulter DELSA 440
instrument. The DELSA 440 is a laser-based multiple
angle particle electrophoresis analyzer that measures the
electrophoretic mobility and zeta potential distribution
simultaneously with the hydrodynamic size of particles
in suspension. Samples of the prepared complexes were
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